The Role of Laser Photocoagulation in Treating Diabetic Macular Edema in the Era of Intravitreal Drug Administration.
/ Publications / The Role of Laser Photocoagulation in Treating Diabetic Macular Edema in the Era of Intravitreal Drug Administration.
The Role of Laser Photocoagulation in Treating Diabetic Macular Edema in the Era of Intravitreal Drug Administration.
Authors: Nozaki M, Ando R, Kimura T, Kato F, Yasukawa T. Medicina
Presented: January 1, 2023
Type: Publications
“In the future, novel treatments such as gene therapy or anti-inflammatory drugs might be poised to play a crucial role in the management of DME. Nevertheless, recent advancements in laser technology and multimodal imaging have demonstrated new potential applications for laser photocoagulation, even in the era of widespread use of anti-VEGF drugs and steroids. These innovative techniques aim to optimize treatment outcomes while minimizing adverse events and alleviating the burden of frequent injections, thereby offering significant value to DME management. These developments instill hope for patients with DME and underscore the importance of ongoing research in the field of laser photocoagulation.”
Related publications and webinars
From Minimally Invasive Procedure to Photocoagulation: Personalized retinal care with Navilas® (Japanese)
- Type:Webinars
- Presented:February 8, 2024
Priv.-Doz. Dr. med. Yoko Miura
On-Demand Webinar: Navilas in der täglichen Praxis
- Type:Webinars
- Presented:February 1, 2017
Dr. Bernd Fassebender
- The treatment strategy and selected parameters presented in content listed here are solely the responsibility of the treating ophthalmologist, who is required to be familiar with the most recent literature/guidelines or recommendations, as well as with the usage of the Navilas Laser System according to the current Operator’s Manual.